click below
click below
Normal Size Small Size show me how
Opioids
Uni of Notts, Addiction & The Brain, first year
| Term | Definition |
|---|---|
| Opioids & their effects | Compounds similar to those naturally in the opium poppy which agonise inhibitory receptors to cause analgesia but not anaesthesia. Act as incredibly potent painkillers, euphorics, & narcotics |
| Dangerous side effects of opioids | High risk of overdose due to inhibition of cells in medulla oblongata & pons of the brainstem causing respiratory depression leading to hypoxia & blood acidosis |
| Types of opioids: Direct derivatives | Active compounds obtained directly from opium resin e.g., morphine |
| Types of opioids: Processed opioid derivatives | Modifying the chemical structure of compounds found in opium such as codeine or heroin. These modifications make it more lipophilic so more crosses the blood brain barrier to be converted back to morphine |
| Types of opioids: Synthetic/semi-synthetic opiates | Organic compounds similar to opium derivatives except synthesised by different precursor molecules that either don't come from opium (synthetic) or do but aren't morphine (semi-synthetic) |
| History of opioids | Have been used in early civilisations but sale & use was completely unregulated in 19th & 20th centuries. A laudanum (Victoria opioid tincture) habit was more acceptable than alcoholism. Heroin was synthesised by Beyer as an alternative to morphine |
| Opioid receptors | Only recently discovered & named after their exogenous ligand (endogenous opioid system hadn't been discovered) to cause rapid hyperpolarisation of the cell. Are metabotropic GPCRs |
| Opioid receptor subtypes | Mu - widely distributed, associated with pain relief & euphoria Kappa - mediates some effects of mu receptors causing dysphoria Peripheral - in targets in the PNS such as small intestine & oesophagus |
| Chronic pain | Severe physical agony lasting for longer than 3 months, it is considered a disease in itself at this point & opioids can be used to treat |
| Pain pathway | Ascending white matter tract. Stimulus triggers nociceptors, dorsal horns of the spinal cord signal the thalamus then somatosensory cortex. Descending midbrain pathway mediates the pain signal |
| Opioids in pain relief | Inhibits dorsal horn of ascending tract & disinhibits periaqueductal cells in the descending pathway. Is good for acute pain but not efficient in treating non-cancer chronic pain |
| Opioids in the reward system | Increase dopamine in the nucleus accumbens by stimulating mu-receptors on GABAa channels on inhibitory interneurons in the Ventral Tagmental Area (VTA) disinhibiting dopamine release |
| Ways of measuring effects of opioids on the reward system (3) | fMRI shows blood flow in the brain but doesn't directly correlate to activity so microdialysis of nucleus accumbens is used. Behaviourally we see how rats will administer intravenously or intracranially |
| Dopamine vs enjoyment | Dopamine triggers pathways causing wanting rather than pleasure so users might not even enjoy opioids, they just want them. Shown by an experiment comparing facial reactions to sweet & sour stimuli as reference for enjoyment |
| Pharmacological adaptations of opioids use (7) | Psychological & physiological changes to oppose the acute effects of opioids includes anhedonia, tremors, increased heartrate, spontaneous ejaculation, sweating, insomnia, depression etc. |
| How many people become addicted | Legal prescription opioids can cause dependency & can lead individuals to seek stronger opioids to continue the effects through illegal means. Now less opioids are prescribed so dependence comes from illegal sources |
| Treatment options (3) | Detoxification with medication, controlled withdrawal & abstinence in controlled settings, & naloxone treatment for strong willed patients |